Intrexon Reports Third Quarter 2019 Financial Results

Go back to Intrexon Reports Third Quarter 2019 Financial Results

Intrexon (XON) Misses Q3 EPS by 11c, Revenues Miss

November 12, 2019 7:31 AM EST

Intrexon (NASDAQ: XON) reported Q3 EPS of ($0.35), $0.11 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $23.04 million versus the consensus estimate of $33 million.

"Intrexon's longstanding focus on Health and, in particular, in cancer therapeutics may be vindicated as Precigen's... More